HOME › DRUGS › NEVIRAPINE
ACTIVE SUBSTANCE / INN

NEVIRAPINE

Brand name(s): Viramune, LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS, STAVUDINE; LAMIVUDINE W/NEVIRAPINE, LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE, VIRAMUNE, NEVIRAPINE, STAVUDINE; LAMIVUDINE; NEVIRAPINE, LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE, Nevirapine Teva, LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
FDA LISTED
EMA LISTED
DISCONTINUED
PRESCRIPTION
WITHDRAWN
NDA205626
NDA022061
ACTIVE SUBSTANCE
Nevirapine
REGULATORS
FDA · EMA
SPONSORS / MAH
STRIDES ACROLAB, TECH ORGANIZED, Teva B.V. 
TOTAL APPLICATIONS
12
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NEVIRAPINEANDA203176TECH ORGANIZEDDiscontinued
LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINENDA205626MICRO LABSDiscontinued
NEVIRAPINEANDA207064CIPLA LIMITEDNone (Tentative Approval)
STAVUDINE; LAMIVUDINE W/NEVIRAPINENDA021854STRIDES ACROLABNone (Tentative Approval)
STAVUDINE; LAMIVUDINE; NEVIRAPINENDA022342EMCURE PHARMANone (Tentative Approval)
NEVIRAPINEANDA077521AUROBINDOPrescription
LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETSNDA200793MATRIX LABSNone (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE; NEVIRAPINENDA021971CIPLA LIMITEDNone (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINENDA022061MATRIX LABSNone (Tentative Approval)
VIRAMUNENDA020933BOEHRINGER INGELHEIMDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ViramuneBoehringer Ingelheim International GmbHAuthorised04/02/1998HIV Infections
Nevirapine TevaTeva B.V. Withdrawn30/11/2009HIV Infections

FULL INTELLIGENCE ON NEVIRAPINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →